The macrophage activation marker soluble CD163 is associated with early allograft dysfunction following liver transplantation

ConclusionsWe observed elevated sCD163 levels in patients with EAD after liver transplantation confirming macrophage activation to play a role in EAD. Thus, sCD163 may be used as an early marker for EAD after liver transplantation, but larger studies are warranted to validate these findings.
Source: Journal of Clinical and Experimental Hepatology - Category: Gastroenterology Source Type: research